-transparent.png){kind=logo}
The present study describes the interaction between carbamazepine (CBZ) and viloxazine, a recently synthesized antidepressant agent. Seven epileptic patients on chronic anticonvulsant therapy showed a significant (p less than 0.005) increase in steady-state serum CBZ levels (from 8.1 +/- 2.5 SD to 12.1 +/- 2.5 SD micrograms/ml) when viloxazine (300 mg/day) was added to the therapy. The effect was associated with the appearance of mild CBZ intoxication. The symptoms of this intoxication (i.e., dizziness, ataxia, fatigue, drowsiness) disappeared rapidly, and serum CBZ levels decreased to the basal values, when viloxazine administration was stopped.
Related Publications
F Pisani, and
M C Narbone, and
A Fazio, and
P Crisafulli, and
G Primerano, and
A A D'Agostino, and
G Oteri, and
R Di Perri
January 1983,
European journal of clinical pharmacology,
F Pisani, and
M C Narbone, and
A Fazio, and
P Crisafulli, and
G Primerano, and
A A D'Agostino, and
G Oteri, and
R Di Perri
January 1980,
Clinical pharmacokinetics,
F Pisani, and
M C Narbone, and
A Fazio, and
P Crisafulli, and
G Primerano, and
A A D'Agostino, and
G Oteri, and
R Di Perri
January 1993,
Neurologia i neurochirurgia polska,
F Pisani, and
M C Narbone, and
A Fazio, and
P Crisafulli, and
G Primerano, and
A A D'Agostino, and
G Oteri, and
R Di Perri
March 2005,
Epilepsy & behavior : E&B,
F Pisani, and
M C Narbone, and
A Fazio, and
P Crisafulli, and
G Primerano, and
A A D'Agostino, and
G Oteri, and
R Di Perri
January 1988,
Epilepsia,
F Pisani, and
M C Narbone, and
A Fazio, and
P Crisafulli, and
G Primerano, and
A A D'Agostino, and
G Oteri, and
R Di Perri
October 1986,
Journal of neurology, neurosurgery, and psychiatry,
F Pisani, and
M C Narbone, and
A Fazio, and
P Crisafulli, and
G Primerano, and
A A D'Agostino, and
G Oteri, and
R Di Perri
August 1994,
Archives of neurology,
F Pisani, and
M C Narbone, and
A Fazio, and
P Crisafulli, and
G Primerano, and
A A D'Agostino, and
G Oteri, and
R Di Perri
April 1973,
Neurology,
F Pisani, and
M C Narbone, and
A Fazio, and
P Crisafulli, and
G Primerano, and
A A D'Agostino, and
G Oteri, and
R Di Perri
October 2009,
Journal of clinical pharmacy and therapeutics,
F Pisani, and
M C Narbone, and
A Fazio, and
P Crisafulli, and
G Primerano, and
A A D'Agostino, and
G Oteri, and
R Di Perri
April 2000,
Epilepsy research,
